Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on April 24, 2025
FEC Sponsors Meta Crypto Oasis 2025 in Dubai — A Premier Web3 Event Set to Redefine Digital Engagement
GlobeNewswire
·
April 24, 2025
Dubai, UAE, April 24, 2025 (GLOBE NEWSWIRE) -- Under the esteemed Dubai Token 2049 banner, Meta Crypto Oasis 2025 is set to launch as one of the year’s most influential Web3 events. Sponsored by FEC, this global gathering will spotlight how everyday …
X4 Pharmaceuticals Announces Reverse Stock Split
GlobeNewswire
·
April 24, 2025
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that its board of directors has determined to effect a one-for-thirty …
Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
GlobeNewswire
·
April 24, 2025
MARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Enable Medicine, a real-world data company providing AI-ready patient, cellular and molecular data, today announced a …
Rezolve Ai Smashes Past $50 Billion in GMV in Explosive start to 2025, Over 50 Major Enterprises Now Live and Scaling
GlobeNewswire
·
April 24, 2025
Now embedded on over 41.9 million consumer devices with 16.5 million monthly active users Delivering 8 billion+ API calls and 27.9 million GeoZone triggers so far this year NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), the company …
Snyk Achieves FedRAMP Moderate Authorization
GlobeNewswire
·
April 24, 2025
BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Snyk, a leader in developer security, today announced it has achieved FedRAMP Moderate Authorization, completing the FedRAMP process for Snyk for Government. This achievement underscores Snyk’s commitment to …
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
GlobeNewswire
·
April 24, 2025
MARLBOROUGH, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, today announced the availability of a new assay designed to advance antibody-drug conjugate (ADC) development in breast cancer. The …
Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data
GlobeNewswire
·
April 24, 2025
April 28th AUA data presentation to highlight study in patients with high-grade non-muscle invasive bladder cancer (HG-NMIBC) Virtual event to be held on April 28, 2025 at 4:30 PM ET CORAL GABLES, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Relmada …
Fourth Annual RetailTech Breakthrough Awards Program Honors World’s Most Innovative Retail Technology Companies
GlobeNewswire
·
April 24, 2025
LOS ANGELES, April 24, 2025 (GLOBE NEWSWIRE) -- RetailTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout retail technology companies, products and services around the globe, today announced the …
ORYZON Raises €30 Million in Capital Increase
GlobeNewswire
·
April 24, 2025
Issued 12,765,958 new shares Priced at €2.35 per share, representing a 15.44% discount on the 5-day VWAP Strong investor demand, with the offering significantly oversubscribed €15 million anchored by a leading US institutional investor Proceeds to fund …
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025
GlobeNewswire
·
April 24, 2025
TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and smallpox TNX-801 protects immunocompromised animals from a lethal challenge with clade IIa monkeypox virus Durability of TNX-801 vaccination shown by six-month …
Wearable Devices Unveils Revolutionary Gesture Mapper for Mudra Link, Ushering in a New Era of Personalized Neural Control
GlobeNewswire
·
April 24, 2025
The new feature empowers users to customize intuitive and touchless interactions, transforming the way they control their digital world. YOKNEAM ILLIT, ISRAEL, April 24, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) ( …
Nerve Renew Under Review & Ingredients Guide | Best Nerve Pain Supplement Explained
GlobeNewswire
·
April 24, 2025
Eagle, Idaho, April 24, 2025 (GLOBE NEWSWIRE) -- There are some occurrences inside the human body that remain a mystery to the medical community. Nerve discomfort is among these mysteries. Knowing that the pain in the fingers, legs, and feet is caused by …
Tonic Greens Review: Will TonicGreens Supplement Work for Immune Support? Read Tonic Greens Official Report!
GlobeNewswire
·
April 24, 2025
Aurora, Colorado, April 24, 2025 (GLOBE NEWSWIRE) -- Lack of immunity is the leading cause of all health problems. It may be caused by age, environmental pollutants, genetic abnormalities, and other reasons. Nature has a remedy, and employing it correctly …
ZenaTech’s ZenaDrone Granted FAA Part 137 Approval for Agricultural Drone Operations Addressing a $6 Billion Global Agricultural Drone Market Growing to $24 Billion by 2032
GlobeNewswire
·
April 24, 2025
VANCOUVER, British Columbia, April 24, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS and …
CoreCard Corporation Schedules First Quarter 2025 Earnings Release and Conference Call
GlobeNewswire
·
April 24, 2025
NORCROSS, Ga., April 24, 2025 (GLOBE NEWSWIRE) -- CoreCard Corporation (NYSE: CCRD), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, intends to hold an investor …
BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™
GlobeNewswire
·
April 24, 2025
(IMAGES BELOW) Complete resolution of lung metastasis confirmed at 4 month follow-up in hormone receptor positive (HR+) breast cancer patient Treatment well-tolerated and patient remains on study with stable disease elsewhere Sustained clinical response …
Kura Oncology to Report First Quarter 2025 Financial Results
GlobeNewswire
·
April 24, 2025
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced it will …
Ace Vision Group Announces Initial Close of $29.4 Million Series B Financing Round
GlobeNewswire
·
April 24, 2025
Funding supports the commercial product development of VisioLite® Device and Laser Scleral Microporation Human Clinical Study. Capital raised to date provides strong financial position to prepare the device for regulatory trials and submissions. BOSTON, …
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy
GlobeNewswire
·
April 24, 2025
- Recently presented data demonstrated sustained functional improvement with DYNE-251 treatment through 18 months - - Data from the fully enrolled DELIVER registrational expansion cohort is planned for late 2025 - WALTHAM, Mass., April 24, 2025 (GLOBE …
Avidicure Launches with $50 Million in Seed Financing to Develop New Multifunctional Antibody Modality to Treat Cancer
GlobeNewswire
·
April 24, 2025
AVC-Boosters are designed as dual agonistic antibodies to safely deliver targeted and potent monotherapy with broad application in oncology Lead product AVC-S-101 is a TROP2-targeting booster being developed for non-small cell lung cancer and multiple …